EP2583757A1 — Manually operable fluid dispensing device
Assigned to Lek Pharmaceuticals dd · Expires 2013-04-24 · 13y expired
What this patent protects
Manually operable fluid dispensing device, comprising a housing (10, 110), an actuation member (30, 130) attached to the housing (10, 110) so that it can be manually actuated in an actuation direction, a movable member (22, 122) being movable in a direction substantially perpendi…
USPTO Abstract
Manually operable fluid dispensing device, comprising a housing (10, 110), an actuation member (30, 130) attached to the housing (10, 110) so that it can be manually actuated in an actuation direction, a movable member (22, 122) being movable in a direction substantially perpendicular to the actuation direction of the actuation member (30, 130) in order to enable a discharge of fluid from the fluid dispensing device, a conversion mechanism for converting a movement of the actuation member (30, 130) into a movement of the moveable member, wherein the conversion mechanism includes a groove (32, 132) and a sliding portion (24, 124) slidably accommodated in the groove (32, 132), with the groove (32, 132) being provided on the actuation member (30, 130) or the movable member (22, 122) and the sliding portion (24, 124) being provided on the other one of the actuation member (30, 130) and the movable member (22, 122).
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.